# Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment

> **NCT00544284** · PHASE1 · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 25 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors
- Lymphoma
- Metastatic Cancer
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** bortezomib
- **DRUG:** temozolomide
- **OTHER:** pharmacological study

## Key facts

- **NCT ID:** NCT00544284
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2013-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00544284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00544284, "Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00544284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*